Predicate |
Object |
contentType |
Clinical Trial, Phase III|Comparative Study|Journal Article |
endingPage |
4 |
issn |
1543-0790 |
issueIdentifier |
11 |
pageRange |
852-4 |
publicationName |
Clinical advances in hematology & oncology : H&O |
startingPage |
852 |
bibliographicCitation |
S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer. Clin Adv Hematol Oncol. 2005 Nov;3(11):852–4. PMID: 16491627. |
date |
200511 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/16491627 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32465 https://portal.issn.org/resource/ISSN/1543-0790 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ |
title |
S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer |
discusses |
http://id.nlm.nih.gov/mesh/M0006270 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0197524 http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0006519 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D001943Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D004164Q000008 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D007093Q000008 http://id.nlm.nih.gov/mesh/D000077557 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000077211 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D004002Q000008 http://id.nlm.nih.gov/mesh/D011237 |